Clik here to view.
The IV2 Alliance, Inc. and Telangana, India Establish Pathway to Advance...
WHITE OAK, Md. Representatives from The IV2 Alliance, Inc., a Maryland non-profit corporation, and the government of the State of Telangana, India, have signed a Memorandum of Understanding (MOU) to...
View ArticleClik here to view.
Dr. Reddy’s Q2 and H1 FY17 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the second quarter and half year ended September 30,...
View ArticleClik here to view.
サンバイオ、日本における外傷性脳損傷を対象としたフェーズ２臨床試験の被験者組み入れ開始のお知らせ
東京 （ビジネスワイヤ） — サンバイオ株式会社（本社:東京都中央区、代表取締役社長：森...
View ArticleClik here to view.
Q2ソリューションズがイルミナと提携しコンパニオン診断薬の能力を拡大
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米ノースカロライナ州モリスビル （ビジネスワイヤ） — 世界的な臨床試験ラボサービス組織のQ2ソリューションズは本日、ゲノムに基づくコンパニオン診断薬（CDx）の当社能力を拡大すると発表しました。この拡大は、Q2ソリューションズ –...
View ArticleClik here to view.
Q2 Solutions与 Illumina合作提升伙伴诊断试剂能力
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 北卡罗莱纳州莫里斯维尔 (美国商业资讯)–全球性临床试验实验室服务组织Q2 Solutions今天宣布拓展其基因组伙伴诊断试剂(CDx)能力。此宣布是Q2 Solutions – EA...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces New Strategic Deal with Gland Pharma in...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has entered into a strategic collaboration with Gland Pharma, a...
View ArticleClik here to view.
First Patient is Enrolled in Global STEMTRA Trial for Traumatic Brain Injury...
MOUNTAIN VIEW, Calif. & TOKYO SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, today announced that the first patient in Japan was enrolled in the...
View ArticleClik here to view.
Acucela Issues Notice of Listing Approval of Kubota Pharmaceutical Holdings
SEATTLE Acucela Inc. (Tokyo:4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
フレックスグローバルが世界的な総合eTMFソリューションをバイエルに提供
英アマーシャム & 米ペンシルバニア州マルバーン （ビジネスワイヤ） — 電子治験マスターファイル（eTMF）技術とTMFサービスをライフサイエンス業界に提供するパイオニア的専門企業のフレックスグローバルは、市場をリードする当社のeTMFであるPhlexEviewが、バイエルの製薬部門向けeTMFソリューションとして成功していることを発表します。...
View ArticleClik here to view.
Vyome Biosciences Administers First In-human Dose of VB 1953 in U.S. Phase 1...
NEW DELHI Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced that it...
View ArticleClik here to view.
AtriCure Announces Approval for the cryoICE™ Platform in Japan
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received approval...
View ArticleClik here to view.
エイトリキュアがcryoICE™プラットフォームの日本での承認を発表
米オハイオ州メーソン （ビジネスワイヤ） — 心房細動（Afib）治療と左心耳（LAA）管理における一流イノベーター企業のエイトリキュア（Nasdaq: ATRC）は本日、cryoICE™プラットフォームおよびCRYO2冷凍アブレーションプローブの承認を厚生労働省より取得したと発表しました。承認により、これらの製品が日本市場で初めて提供可能になります。...
View ArticleClik here to view.
Custom PCR Master Mixes Ship in 10 Days with New Promega cGMP PCR Kit for...
MADISON, Wis. Now available, the Promega PCR Optimization Kit allows customers to rapidly define their own unique PCR master mix manufactured under cGMP for research or clinical use. The user’s...
View ArticleClik here to view.
Takeda to Present Broad Range of Clinical Data During 58th American Society...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 16 company-sponsored abstracts at the 58th American Society of...
View ArticleClik here to view.
Boyalife Announces Recent Changes to Management and the Board of Directors of...
WUXI, China Boyalife Investment Inc. and Boyalife (Hong Kong) Limited (collectively, “Boyalife”), as the majority shareholders of Cesca Therapeutics Inc. (NASDAQ: KOOL) (the “Company), an autologous...
View ArticleClik here to view.
NAMSA上海实验室开张，扩大在华服务项目
俄亥俄州托莱多和上海 (美国商业资讯) – 全球唯一的医学研究组织(MRO) NAMSA欣然宣布，该组织最先进的临床前医疗器械研究实验室在中国上海开张。这是该组织在亚太区的第三个据点，代表NAMSA对基于中国的实验室服务不断增加投资，并且致力于帮助客户更有效率地将产品推向全球市场。...
View ArticleClik here to view.
Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical...
BOTHELL, Wash. & CAMBRIDGE, Mass. Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced completion of patient enrollment in the ECHELON-2...
View ArticleClik here to view.
Adare Pharmaceuticals任命Peter Richardson博士为研发副总裁兼首席医学官
新泽西州普林斯顿 (美国商业资讯) — Adare Pharmaceuticals, Inc.宣布，Peter Richardson博士已加入该公司，任研发副总裁兼首席医学官。Richardson博士将负责领导本公司在世界各地的研发活动，并负责公司后续产品线的成功开发。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Bioventus任命Andrew McCartney担任EMEA国际业务董事总经理
北卡罗来纳州DURHAM (美国商业资讯)–骨愈合解决方案全球领导者Bioventus今日宣布任命Andrew McCartney担任董事总经理，负责领导欧洲、中东和非洲(EMEA)的国际业务，推动该地区Active Healing Therapies产品组合的增长。此外，他还是荷兰霍夫多普(Hoofddorp)国际总部负责人。 Smart News...
View ArticleTaro Provides Results for September 30, 2016
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and six months ended September 30, 2016. Quarter...
View Article